# The Effect of Short-Term and High-Intensity Functional Circuit Training on Plasma Lipidome Profiles of People Living with and Without HIV

**Authors:** Marcos Yukio Yoshinaga, Flávio Gomez Faria, Adriano de Britto Chaves-Filho, Sayuri Miyamoto, Tania Cristina Pithon-Curi, Giselle Cristina Bueno, Bruno Ferrari Silva, Sidney Barnabé Peres, Solange Marta Franzoi de Moraes

PMC · DOI: 10.3390/metabo16010016 · 2025-12-24

## TL;DR

This study shows that short-term high-intensity exercise can improve lipid profiles in people with and without HIV, potentially reducing metabolic risks.

## Contribution

The study identifies specific lipidomic changes in people with HIV following exercise, offering new insights into metabolic responses.

## Key findings

- Exercise training equalized adiponectin and phosphatidylcholine levels in people with HIV.
- Control subjects showed reduced triglycerides and ceramides after training.
- People with HIV had increased diglycerides and acylcarnitines, suggesting metabolic improvements.

## Abstract

Background/Objectives: Both HIV infection and antiretroviral therapy contribute to dyslipidemia and abnormal body fat distribution in people living with HIV (PLWH). Exercise training is an effective intervention to protect against these metabolic changes. However, little is known about the mechanisms underlying the impact of exercise training on lipid metabolism in PLWH. This study aimed to comparatively evaluate the effect of high-intensity functional circuit training on the plasma lipidome of PLWH and HIV-negative subjects (control). Methods: PLWH (n = 13) and control (n = 14) were submitted to 8 weeks of exercise training. Body composition, anthropometric, and biochemical parameters were measured. Plasma was obtained in a fasting state for lipidomic analysis. Results: Anthropometric and biochemical parameters revealed lower levels of leptin, HDL-C, body fat %, and BMI combined with elevated aspartate transaminase (AST) and Homeostasis Model Assessment of β-cell function (HOMA_beta) in PLWH when compared to control subjects that persisted from baseline to post-exercise training. Nonetheless, contrasting levels of adiponectin, fasting insulin, and phosphatidylcholine-containing lipids observed at baseline were equalized after training in PLWH. In control subjects, significant reductions in concentrations of triglycerides alongside phosphatidylinositol and glycosylated ceramides were observed post-exercise training. By contrast, PWLH displayed an increase in diglycerides, acylcarnitines, and free cholesterol levels after exercise training, together with decreased concentrations of free fatty acids, cholesteryl esters, and glycosylated ceramides. Conclusions: In addition to specific lipidome alterations in each group, particularly driven by improved insulin resistance in PLWH, this study showed concomitant modulation of several glycerophospholipids and sphingolipids, suggesting health-promoting effects of short-term exercise training. Collectively, these modulated lipid species represent interesting targets for future lipidomic-based studies evaluating not only the effects of exercise training but also the molecular mechanisms resulting in a healthier plasma lipidome profile.

## Linked entities

- **Chemicals:** diglycerides (PubChem CID 6026790)

## Full-text entities

- **Genes:** LEP (leptin) [NCBI Gene 3952] {aka LEPD, OB, OBS}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, ADIPOQ (adiponectin, C1Q and collagen domain containing) [NCBI Gene 9370] {aka ACDC, ACRP30, ADIPQTL1, ADPN, APM-1, APM1}, SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}
- **Diseases:** HIV (MESH:D015658), abnormal body fat distribution (MESH:D020243), insulin resistance (MESH:D007333), dyslipidemia (MESH:D050171)
- **Chemicals:** phosphatidylinositol (MESH:D010716), cholesteryl esters (MESH:D002788), lipid (MESH:D008055), free fatty acids (MESH:D005230), sphingolipids (MESH:D013107), free cholesterol (-), acylcarnitines (MESH:C116917), phosphatidylcholine (MESH:D010713), diglycerides (MESH:D004075), triglycerides (MESH:D014280), glycerophospholipids (MESH:D020404)
- **Species:** Human immunodeficiency virus 1 (no rank) [taxon 11676]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12844262/full.md

---
Source: https://tomesphere.com/paper/PMC12844262